| Issue |
BIO Web Conf.
Volume 182, 2025
The 3rd International Conference on Food Science and Bio-medicine (ICFSB 2025)
|
|
|---|---|---|
| Article Number | 02003 | |
| Number of page(s) | 5 | |
| Section | Biomedical Research and Applications | |
| DOI | https://doi.org/10.1051/bioconf/202518202003 | |
| Published online | 02 July 2025 | |
The Progress In Research Ontargeted And Immunotherapy For Non-Small Cell Lung Cancer
Medical school, Jiaying university, Meizhou, Guangdong Province, 514031, China
* Corresponding author’s e-mail: 183594124@qq.com
The incidence and mortality rates of non-small cell lung cancer (NSCLC) are alarmingly high, positioning it as one of the most critical diseases that require immediate attention. This paper first outlines the current status of NSCLC, followed by a discussion of traditional treatment modalities, including surgery, chemotherapy, and radiotherapy, as well as emerging options such as targeted therapy and immunotherapy. Finally, it offers a summary and outlook on the overall landscape of NSCLC treatment, emphasizing the belief that ongoing and in-depth research on NSCLC will continually benefit affected patients.
© The Authors, published by EDP Sciences, 2025
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.